In a study by Xiao Nian Zhu et al., 2017 including 436 patients with HCC, the presence of single nucleotide polymorphism (SNP) MLH1, rs1800734, was shown to correlate with tumor size, stage, and AFP level of HCC patients (p < 0.05). Here, MLH1 is linked to hepatocellular carcinoma.